10.28.22
Amy Lynn Tally, Cold Spring, KY.
Assigned to The Procter & Gamble Company, Cincinnati, OH.
Filed: 5/31/18
Issued: 9/27/22
An absorbent article configured to provide accurate bodily exudate visualization when viewing a wearer-facing surface of the absorbent article, the absorbent article comprising: a liquid permeable topsheet forming a portion of the wearer-facing surface of the absorbent article; a liquid impermeable backsheet comprising a first backsheet region having a first opacity and a second backsheet region having a second opacity, wherein the first opacity is less than the second opacity; an absorbent core positioned at least partially intermediate the liquid permeable topsheet and the liquid impermeable backsheet; and an outer cover nonwoven material comprising at least one window, wherein the window is formed by a first region of the outer cover nonwoven material having lower opacity than a surrounding second region; wherein the wearer-facing surface exhibits a Delta C* of greater than about 24 and less than about 50 when the absorbent article is subjected to a Bodily Exudate Visualization Test.
Assigned to The Procter & Gamble Company, Cincinnati, OH.
Filed: 5/31/18
Issued: 9/27/22
An absorbent article configured to provide accurate bodily exudate visualization when viewing a wearer-facing surface of the absorbent article, the absorbent article comprising: a liquid permeable topsheet forming a portion of the wearer-facing surface of the absorbent article; a liquid impermeable backsheet comprising a first backsheet region having a first opacity and a second backsheet region having a second opacity, wherein the first opacity is less than the second opacity; an absorbent core positioned at least partially intermediate the liquid permeable topsheet and the liquid impermeable backsheet; and an outer cover nonwoven material comprising at least one window, wherein the window is formed by a first region of the outer cover nonwoven material having lower opacity than a surrounding second region; wherein the wearer-facing surface exhibits a Delta C* of greater than about 24 and less than about 50 when the absorbent article is subjected to a Bodily Exudate Visualization Test.